Puma Biotechnology Inc - stock earnings
PBYI Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | 0.26 / -0.22 | - | - / 41.9 million | - |
PBYI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 12.3 million USD | 72.2 million USD |
| 2023Q3 | 5.8 million USD | 56.1 million USD |
| 2023Q2 | 2.1 million USD | 54.6 million USD |
| 2023Q1 | 1.4 million USD | 52.8 million USD |
| 2022Q4 | -5.6 million USD | 65.7 million USD |
| 2022Q3 | -360000 USD | 57.1 million USD |
| 2022Q2 | 9.4 million USD | 59.5 million USD |
| 2022Q1 | -3.4 million USD | 45.7 million USD |
| 2021Q4 | 4.2 million USD | 55.4 million USD |
| 2021Q3 | -44.7 million USD | 46.2 million USD |
| 2021Q2 | -5.1 million USD | 53.4 million USD |
| 2021Q1 | 16.5 million USD | 98.2 million USD |
| 2020Q4 | -15.0 million USD | 52.6 million USD |
| 2020Q3 | -31.5 million USD | 50.8 million USD |
| 2020Q2 | 3.4 million USD | 70.6 million USD |
| 2020Q1 | -16.9 million USD | 51.2 million USD |
| 2019Q4 | -11.2 million USD | 62.9 million USD |
| 2019Q3 | -16.9 million USD | 56.4 million USD |
| 2019Q2 | -37.4 million USD | 53.9 million USD |
| 2019Q1 | -10.1 million USD | 99.1 million USD |
| 2018Q4 | -30.7 million USD | 71.1 million USD |
| 2018Q3 | -14.2 million USD | 62.6 million USD |
| 2018Q2 | -44.3 million USD | 50.8 million USD |
| 2018Q1 | -24.3 million USD | 66.5 million USD |
| 2017Q4 | -64.1 million USD | 21.6 million USD |
| 2017Q3 | -77.2 million USD | 6.1 million USD |
| 2017Q2 | -77.8 million USD | ? USD |
| 2017Q1 | -72.9 million USD | ? USD |
| 2016Q4 | -72.7 million USD | ? USD |
| 2016Q3 | -65.8 million USD | ? USD |
| 2016Q2 | -66.6 million USD | ? USD |
| 2016Q1 | -71.0 million USD | ? USD |
| 2015Q4 | -61.7 million USD | ? USD |
| 2015Q3 | -60.4 million USD | ? USD |
| 2015Q2 | -64.7 million USD | ? USD |
| 2015Q1 | -52.5 million USD | ? USD |
| 2014Q4 | -47.5 million USD | ? USD |
| 2014Q3 | -35.8 million USD | ? USD |
| 2014Q2 | -38.8 million USD | ? USD |
| 2014Q1 | -19.8 million USD | ? USD |
| 2013Q4 | -15.9 million USD | ? USD |
| 2013Q3 | -14.3 million USD | ? USD |
| 2013Q2 | -12.7 million USD | ? USD |
| 2013Q1 | -21.9 million USD | ? USD |
| 2012Q4 | -21.9 million USD | ? USD |
| 2012Q3 | -25.9 million USD | ? USD |
| 2012Q2 | -14.8 million USD | ? USD |
| 2012Q1 | -11.8 million USD | ? USD |
| 2011Q4 | -10.2 million USD | -281096 USD |
| 2011Q3 | -4962 USD | ? USD |
| 2011Q2 | -3312 USD | ? USD |
| 2011Q1 | -6883 USD | ? USD |
| 2010Q4 | -5638 USD | ? USD |
| 2010Q3 | -3203 USD | ? USD |
| 2010Q2 | -2438 USD | ? USD |
| 2010Q1 | -4697 USD | ? USD |
| 2009Q4 | -3312 USD | ? USD |
| 2009Q3 | -3308 USD | ? USD |
| 2009Q2 | -4209 USD | ? USD |
| 2009Q1 | -6007 USD | ? USD |
| 2008Q4 | -2249 USD | ? USD |
| 2008Q3 | -3968 USD | ? USD |
| 2008Q2 | -3375 USD | ? USD |
| 2008Q1 | -4491 USD | ? USD |
| 2007Q4 | -15.1 million USD | ? USD |
PBYI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 21.6 million USD | 235.6 million USD |
| 2022 | 912000 USD | 228.0 million USD |
| 2021 | -29.1 million USD | 253.2 million USD |
| 2020 | -60.0 million USD | 225.1 million USD |
| 2019 | -82.7 million USD | 272.3 million USD |
| 2018 | -113.6 million USD | 251.0 million USD |
| 2017 | -292.0 million USD | 27.7 million USD |
| 2016 | -276.0 million USD | ? USD |
| 2015 | -239.3 million USD | ? USD |
| 2014 | -142.0 million USD | ? USD |
| 2013 | -54.7 million USD | ? USD |
| 2012 | -74.3 million USD | ? USD |
| 2011 | -10.2 million USD | -281096 USD |
| 2010 | -15976 USD | ? USD |
| 2009 | -16836 USD | ? USD |
| 2008 | -14083 USD | ? USD |
| 2007 | -15.1 million USD | ? USD |
PBYI
Price: $4.93
52 week price:
Earnings Per Share: 0.45 USD
P/E Ratio: 72
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 234700
Ebitda: -76.5 millionMarket Capitalization: 272.9 million